A Clinical Study of SHR-4685 on Safety, Tolerability and Pharmacokinetics in Participants With Solid Tumors

NCT07676903 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: SHR-4685

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.